Cancer Sequencing with High Coverage on Two Platforms Improves Mutation Detection, Baylor Team Says

The Baylor researchers propose to sequence tumor-normal pairs with 60-fold coverage or more on two different sequencing platforms "to get a real handle on false positive and false negative rates that occur in cancer sequencing."